A Dispensing Comparison of a Test Daily 1 Day Lens Against a Control 1 Day Lens.

Sponsor
Coopervision, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT03951610
Collaborator
(none)
52
2
2
3.4
26
7.7

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the dispensing performance of somofilcon A test 1 day contact lens against somofilcon A control 1 day contact lens.

Condition or Disease Intervention/Treatment Phase
  • Device: Test lens
  • Device: Control lens
N/A

Detailed Description

The purpose of this study is to evaluate the clinical performance of a silicone-hydrogel test contact lens compared to the commercially available silicone-hydrogel (control) contact lens when worn over one week for each lens type in a randomized, bilateral, cross-over, dispensing study on a daily disposable basis.

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
This will be a, prospective, double-masked, randomized, bilateral, 1 week cross-over, dispensing studyThis will be a, prospective, double-masked, randomized, bilateral, 1 week cross-over, dispensing study
Masking:
Double (Participant, Investigator)
Masking Description:
Double (participant and investigator)
Primary Purpose:
Treatment
Official Title:
A Dispensing Clinical Trial of Invigor 1 Daily Disposable Lens Against Clariti 1-day Lens
Actual Study Start Date :
Feb 21, 2019
Actual Primary Completion Date :
Apr 5, 2019
Actual Study Completion Date :
Jun 4, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Test lens

Subjects wearing the test lens for one week, either randomized as the first or second pair.

Device: Test lens
contact lens
Other Names:
  • Invigor I DD lens
  • Somofilcon A 1 day Test
  • Device: Control lens
    contact lens
    Other Names:
  • Clariti 1-day
  • Somofilcon A 1 day control
  • Active Comparator: Control lens

    Subjects wearing the control lens for one week, either randomized as the first or second pair.

    Device: Test lens
    contact lens
    Other Names:
  • Invigor I DD lens
  • Somofilcon A 1 day Test
  • Device: Control lens
    contact lens
    Other Names:
  • Clariti 1-day
  • Somofilcon A 1 day control
  • Outcome Measures

    Primary Outcome Measures

    1. Number of Participants With Lens Centration [Baseline]

      Centration: Grade degree of Centration (Optimally Centered, Slightly Decentered (<0.5mm Nasal (N), T (Temporal), S (superior), I (inferior), Extremely Decentered (>0.5mm N T S I)

    2. Number of Participants With Lens Centration [1 week]

      Centration: Grade degree of Centration (Optimally Centered, Slightly Decentered (<0.5mm Nasal (N), T (Temporal), S (superior), I (inferior), Extremely Decentered (>0.5mm N T S I)

    3. Post Blink Movement [Baseline]

      Post Blink Movement (Amount of movement to the nearest 0.1mm immediately after the blink)

    4. Post Blink Movement [1 week]

      Post Blink Movement (Amount of movement to the nearest 0.1mm immediately after the blink)

    5. Primary Gaze Lag [baseline]

      Primary Gaze Lag (measured in mm at 0.1mm steps)

    6. Primary Gaze Lag [1 week]

      Primary Gaze Lag (measured in mm at 0.1mm steps)

    7. Up Gaze Lag [Baseline]

      Up Gaze Lag (measured in mm at 0.1mm steps)

    8. Up Gaze Lag [1 week]

      Up Gaze Lag (measured in mm at 0.1mm steps)

    9. Push-Up Tightness [baseline]

      Push-Up Tightness (measured in 1% steps where 0% Falls from cornea without lid support, 50% optimum, 100% no movement)

    10. Push-Up Tightness [1 week]

      Push-Up Tightness (measured in 1% steps where 0% Falls from cornea without lid support, 50% optimum, 100% no movement)

    11. Overall Fit Acceptance [Baseline]

      Overall fit acceptance assessed on a scale of 0-4 (0=unacceptable - cant be worn, 1 =Acceptable -Poor/worn under supervision, 2 =Acceptable -Fair, prefer refit, 3 = Acceptable-Good, 4 =Acceptable -Optimum

    12. Overall Fit Acceptance [1 week]

      Overall fit acceptance assessed on a scale of 0-4 (0=unacceptable - cant be worn, 1 =Acceptable -Poor/worn under supervision, 2 =Acceptable -Fair, prefer refit, 3 = Acceptable-Good, 4 =Acceptable -Optimum

    13. Number of Participants With Overall Lens Fit Impression [Baseline]

      Overall Lens Fit Impression (2=Reduced movement, unacceptable, 1 = Reduced movement acceptable, 0 - Optimal movement, -1 =Excessive movement acceptable, -2 Excessive movement unacceptable

    14. Number of Participants With Overall Lens Fit Impression [1 week]

      Overall Lens Fit Impression (2=Reduced movement, unacceptable, 1 = Reduced movement acceptable, 0 - Optimal movement, -1 =Excessive movement acceptable, -2 Excessive movement unacceptable

    Secondary Outcome Measures

    1. Subjective Comfort Rating [Baseline]

      Subjective comfort scored 0-10 (0-10 scale, 0=uncomfortable, 10 = comfortable)

    2. Subjective Comfort Rating [1-week]

      Subjective comfort scored 0-10 (0-10 scale, 0=uncomfortable, 10 = comfortable)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Has had a self-reported oculo-visual examination in the last two years.

    • Is at least 18 years of age and has full legal capacity to volunteer.

    • Has read and understood the information consent letter.

    • Is willing and able to follow instructions and maintain the appointment schedule.

    • Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected.

    • Currently wears soft contact lenses (average wearing of 8 hours/day and 5 days/week) without the need of using rewetting drops

    • Requires spectacle lens spherical powers between -1.00 to -5.75 diopters sphere (0.25D steps).

    • Has no more than 0.75 diopters of refractive astigmatism.

    • Has clear corneas and no active ocular disease.

    • Has not worn lenses for at least 12 hours before the examination.

    • Has a usable pair of spectacle lenses if required for transportation to the site for the initial visit

    Exclusion Criteria:
    • Is presently participating in any other clinical or research study including eye related clinical or research study.

    • Has never worn contact lenses before.

    • Has any systemic disease affecting ocular health.

    • Has any active ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.

    • Is using any systemic or topical medications that will affect a study outcome variable, and/or ocular health.

    • Has any known sensitivity to fluorescein dye or products to be used in the study.

    • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.

    • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.

    • Is aphakic.

    • Has undergone corneal refractive surgery.

    • Is pregnant, lactating, or planning a pregnancy at the time of enrollment (by verbal confirmation at the screening visit).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Eye Center at Ketchum Health Anaheim California United States 92807
    2 Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University Bloomington Indiana United States 47405

    Sponsors and Collaborators

    • Coopervision, Inc.

    Investigators

    None specified.

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Coopervision, Inc.
    ClinicalTrials.gov Identifier:
    NCT03951610
    Other Study ID Numbers:
    • CV-19-01
    First Posted:
    May 15, 2019
    Last Update Posted:
    Jun 18, 2020
    Last Verified:
    May 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Test Lens Then Control Lens Control Lens Then Test Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week then the control lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week then the test lens for one week. Control lens: contact lens
    Period Title: First Intervention
    STARTED 27 25
    COMPLETED 27 25
    NOT COMPLETED 0 0
    Period Title: First Intervention
    STARTED 27 25
    COMPLETED 27 25
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title Overall Study
    Arm/Group Description Total Participants
    Overall Participants 52
    Age (Count of Participants)
    <=18 years
    0
    0%
    Between 18 and 65 years
    52
    100%
    >=65 years
    0
    0%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    27
    (6)
    Sex: Female, Male (Count of Participants)
    Female
    34
    65.4%
    Male
    18
    34.6%
    Race and Ethnicity Not Collected (Count of Participants)
    Region of Enrollment (participants) [Number]
    United States
    52
    100%

    Outcome Measures

    1. Primary Outcome
    Title Number of Participants With Lens Centration
    Description Centration: Grade degree of Centration (Optimally Centered, Slightly Decentered (<0.5mm Nasal (N), T (Temporal), S (superior), I (inferior), Extremely Decentered (>0.5mm N T S I)
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Optimal
    17
    32.7%
    12
    NaN
    Slightly Decentered
    34
    65.4%
    39
    NaN
    Extreme Decentered
    1
    1.9%
    1
    NaN
    2. Primary Outcome
    Title Number of Participants With Lens Centration
    Description Centration: Grade degree of Centration (Optimally Centered, Slightly Decentered (<0.5mm Nasal (N), T (Temporal), S (superior), I (inferior), Extremely Decentered (>0.5mm N T S I)
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Optimal
    20
    38.5%
    16
    NaN
    Slightly Decentered
    31
    59.6%
    36
    NaN
    Extreme Decentered
    1
    1.9%
    0
    NaN
    3. Primary Outcome
    Title Post Blink Movement
    Description Post Blink Movement (Amount of movement to the nearest 0.1mm immediately after the blink)
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [millimeters (mm)]
    0.25
    (0.10)
    0.26
    (0.09)
    4. Primary Outcome
    Title Post Blink Movement
    Description Post Blink Movement (Amount of movement to the nearest 0.1mm immediately after the blink)
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [millimeters (mm)]
    0.26
    (0.12)
    0.25
    (0.12)
    5. Primary Outcome
    Title Primary Gaze Lag
    Description Primary Gaze Lag (measured in mm at 0.1mm steps)
    Time Frame baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [millimeters (mm)]
    0.22
    (0.12)
    0.25
    (0.16)
    6. Primary Outcome
    Title Primary Gaze Lag
    Description Primary Gaze Lag (measured in mm at 0.1mm steps)
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [millimeters (mm)]
    0.23
    (0.12)
    0.22
    (0.15)
    7. Primary Outcome
    Title Up Gaze Lag
    Description Up Gaze Lag (measured in mm at 0.1mm steps)
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [millimeters (mm)]
    0.28
    (0.10)
    0.31
    (0.12)
    8. Primary Outcome
    Title Up Gaze Lag
    Description Up Gaze Lag (measured in mm at 0.1mm steps)
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [millimeters (mm)]
    0.28
    (0.12)
    0.29
    (0.20)
    9. Primary Outcome
    Title Push-Up Tightness
    Description Push-Up Tightness (measured in 1% steps where 0% Falls from cornea without lid support, 50% optimum, 100% no movement)
    Time Frame baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [percentage]
    46
    (6)
    47
    (4)
    10. Primary Outcome
    Title Push-Up Tightness
    Description Push-Up Tightness (measured in 1% steps where 0% Falls from cornea without lid support, 50% optimum, 100% no movement)
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [percentage]
    45
    (6)
    48
    (9)
    11. Primary Outcome
    Title Overall Fit Acceptance
    Description Overall fit acceptance assessed on a scale of 0-4 (0=unacceptable - cant be worn, 1 =Acceptable -Poor/worn under supervision, 2 =Acceptable -Fair, prefer refit, 3 = Acceptable-Good, 4 =Acceptable -Optimum
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [units on a scale]
    3.12
    (0.39)
    3.08
    (0.36)
    12. Primary Outcome
    Title Overall Fit Acceptance
    Description Overall fit acceptance assessed on a scale of 0-4 (0=unacceptable - cant be worn, 1 =Acceptable -Poor/worn under supervision, 2 =Acceptable -Fair, prefer refit, 3 = Acceptable-Good, 4 =Acceptable -Optimum
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [units on a scale]
    3.12
    (0.41)
    3.13
    (0.44)
    13. Primary Outcome
    Title Number of Participants With Overall Lens Fit Impression
    Description Overall Lens Fit Impression (2=Reduced movement, unacceptable, 1 = Reduced movement acceptable, 0 - Optimal movement, -1 =Excessive movement acceptable, -2 Excessive movement unacceptable
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Reduced Unacceptable
    0
    0%
    0
    NaN
    Reduced Acceptable
    7
    13.5%
    7
    NaN
    Optimal
    43
    82.7%
    44
    NaN
    Excessive Acceptable
    2
    3.8%
    1
    NaN
    Excessive Unacceptable
    0
    0%
    0
    NaN
    14. Primary Outcome
    Title Number of Participants With Overall Lens Fit Impression
    Description Overall Lens Fit Impression (2=Reduced movement, unacceptable, 1 = Reduced movement acceptable, 0 - Optimal movement, -1 =Excessive movement acceptable, -2 Excessive movement unacceptable
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Reduced Unacceptable
    0
    0%
    1
    NaN
    Reduced Acceptable
    9
    17.3%
    9
    NaN
    Optimal
    41
    78.8%
    41
    NaN
    Excessive Acceptable
    2
    3.8%
    1
    NaN
    Excessive Unacceptable
    0
    0%
    0
    NaN
    15. Secondary Outcome
    Title Subjective Comfort Rating
    Description Subjective comfort scored 0-10 (0-10 scale, 0=uncomfortable, 10 = comfortable)
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [units on a scale]
    9.0
    (1.2)
    9.4
    (0.9)
    16. Secondary Outcome
    Title Subjective Comfort Rating
    Description Subjective comfort scored 0-10 (0-10 scale, 0=uncomfortable, 10 = comfortable)
    Time Frame 1-week

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the control lens for one week. Control lens: contact lens
    Measure Participants 52 52
    Mean (Standard Deviation) [units on a scale]
    9.1
    (1.1)
    9.1
    (1.0)

    Adverse Events

    Time Frame From baseline up to 1 week for each intervention, a total of 2 weeks.
    Adverse Event Reporting Description
    Arm/Group Title Test Lens Control Lens
    Arm/Group Description Subjects were randomized to wear the test lens for one week. Test lens: contact lens Subjects were randomized to wear the test lens for one week. Control lens: contact lens
    All Cause Mortality
    Test Lens Control Lens
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/52 (0%) 0/52 (0%)
    Serious Adverse Events
    Test Lens Control Lens
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/52 (0%) 0/52 (0%)
    Other (Not Including Serious) Adverse Events
    Test Lens Control Lens
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/52 (0%) 0/52 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Myhanh Nguyen
    Organization CooperVision, Inc.
    Phone 925-730-6716
    Email mnguyen@coopervision.com
    Responsible Party:
    Coopervision, Inc.
    ClinicalTrials.gov Identifier:
    NCT03951610
    Other Study ID Numbers:
    • CV-19-01
    First Posted:
    May 15, 2019
    Last Update Posted:
    Jun 18, 2020
    Last Verified:
    May 1, 2020